|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/17/2024 |
$2.77 |
$2.80 |
$2.43 |
$2.44 |
3.31M | 04/18/2024 |
$2.45 |
$2.46 |
$2.33 |
$2.33 |
2.78M | 04/19/2024 |
$2.31 |
$2.48 |
$2.28 |
$2.40 |
2.34M | 04/22/2024 |
$2.41 |
$2.52 |
$2.36 |
$2.51 |
2.16M | 04/23/2024 |
$2.50 |
$2.73 |
$2.45 |
$2.58 |
1.52M |
|
Adaptive Biotechnologies is a commercial-stage company developing the field of immune medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Co.'s clinical diagnostic product, clonoSEQ, is authorized for the detection and monitoring of minimal residual disease in patients with multiple myeloma, B cell acute lymphoblastic leukemia and chronic lymphocytic leukemia and is also available as a CLIA-validated laboratory developed test for patients with other lymphoid cancers. Using its collaboration with Microsoft Corporation, Co. is creating a map of the interaction between the immune system and disease. | |
|
Adaptive Biotechnologies (ADPT) has the following price history information. Looking back at ADPT historical stock prices for the last five trading days, on April 17, 2024, ADPT opened at $2.77, traded as high as $2.80 and as low as $2.43, and closed at $2.44. Trading volume was a total of 3.31M shares. On April 18, 2024, ADPT opened at $2.45, traded as high as $2.46 and as low as $2.33, and closed at $2.33. Trading volume was a total of 2.78M shares. On April 19, 2024, ADPT opened at $2.31, traded as high as $2.48 and as low as $2.28, and closed at $2.40. Trading volume was a total of 2.34M shares. On April 22, 2024, ADPT opened at $2.41, traded as high as $2.52 and as low as $2.36, and closed at $2.51. Trading volume was a total of 2.16M shares. On April 23, 2024, ADPT opened at $2.50, traded as high as $2.73 and as low as $2.45, and closed at $2.58. Trading volume was a total of 1.52M shares.
ADPT Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Adaptive Biotechnologies shares, starting with a $10,000 purchase of ADPT, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/27/2019 |
|
End date: |
04/23/2024 |
|
Start price/share: |
$40.30 |
|
End price/share: |
$2.58 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-93.60% |
|
Average Annual Total Return: |
-43.41% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$640.29 |
|
Years: |
4.83 |
|
|
|
Date |
Close |
04/17/2024 | $2.44 | 04/18/2024 | $2.33 | 04/19/2024 | $2.40 | 04/22/2024 | $2.51 | 04/23/2024 | $2.58 |
|
|